Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.
作者信息
Vinograd Cheryl A, Bussel James B
出版信息
Haematologica. 2010 Nov;95(11):1807-11. doi: 10.3324/haematol.2010.030148.
Abstract
摘要
相似文献
1
Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.胎儿同种免疫性血小板减少症的产前治疗：当前观点
Haematologica. 2010 Nov;95(11):1807-11. doi: 10.3324/haematol.2010.030148.
2
Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.胎儿同种免疫性血小板减少症和母亲静脉内免疫球蛋白输注。
Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9.
3
Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts.反复宫内 IgG 输注不能增加胎儿血小板计数胎儿同种免疫性血小板减少症。
Vox Sang. 2010 Nov;99(4):348-53. doi: 10.1111/j.1423-0410.2010.01367.x.
4
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.胎儿 - 新生儿同种免疫性血小板减少症后续妊娠治疗中胎儿采样的省略
Am J Obstet Gynecol. 2016 Oct;215(4):471.e1-9. doi: 10.1016/j.ajog.2016.04.033. Epub 2016 Apr 27.
5
Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.母亲接受静脉注射免疫球蛋白治疗后同种免疫性血小板减少症的新生儿结局
Blood Transfus. 2015 Jan;13(1):66-71. doi: 10.2450/2014.0309-13. Epub 2014 Jun 19.
6
Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry.新生儿同种免疫性血小板减少症的当代管理：静脉注射免疫球蛋白时代的良好结局：来自澳大利亚新生儿同种免疫性血小板减少症登记处的结果
J Matern Fetal Neonatal Med. 2017 Oct;30(20):2488-2494. doi: 10.1080/14767058.2016.1253064. Epub 2016 Nov 24.
7
New developments in fetal and neonatal alloimmune thrombocytopenia.胎儿和新生儿同种免疫性血小板减少症的新进展。
Am J Obstet Gynecol. 2021 Aug;225(2):120-127. doi: 10.1016/j.ajog.2021.04.211. Epub 2021 Apr 8.
8
Neonatal alloimmune thrombocytopenia: antenatal management.新生儿同种免疫性血小板减少症：产前管理
Am J Obstet Gynecol. 2000 May;182(5):1233-8. doi: 10.1067/mob.2000.104841.
9
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.在对胎儿和新生儿同种免疫性血小板减少症进行产前静脉注射免疫球蛋白治疗期间，A型血母亲更易出现贫血。
Transfusion. 2016 Oct;56(10):2449-2454. doi: 10.1111/trf.13779. Epub 2016 Sep 9.
10
Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.低剂量与标准剂量静脉注射免疫球蛋白预防胎儿和新生儿同种免疫性血小板减少症中的胎儿颅内出血：一项随机试验。
Fetal Diagn Ther. 2015;38(2):147-53. doi: 10.1159/000380907. Epub 2015 Apr 17.
引用本文的文献
1
Neonatal Immune Incompatibilities between Newborn and Mother.新生儿与母亲之间的新生儿免疫不相容性。
J Clin Med. 2020 May 14;9(5):1470. doi: 10.3390/jcm9051470.
2
Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.胎儿及新生儿同种免疫性血小板减少症的当前观点——日益增加的临床关注及新的治疗机遇
Int J Womens Health. 2017 Apr 19;9:223-234. doi: 10.2147/IJWH.S90753. eCollection 2017.
3
Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.血小板与血小板同种抗原：来自胎儿及新生儿同种免疫性血小板减少症人类患者和动物模型的经验教训。
Genes Dis. 2015 Jun 1;2(2):173-185. doi: 10.1016/j.gendis.2015.02.003.
4
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies.含抗HPA-1a抗体的母体血清对体外巨核细胞生成的抑制作用。
Blood. 2015 Sep 3;126(10):1234-6. doi: 10.1182/blood-2014-11-611020. Epub 2015 Jul 24.
5
Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report.第二孕期新生儿同种免疫性血小板减少症的成功管理：一例报告
Einstein (Sao Paulo). 2014 Jan-Mar;12(1):96-9. doi: 10.1590/s1679-45082014rc2729.
6
Fetal and neonatal alloimmune thrombocytopenia.胎儿及新生儿同种免疫性血小板减少症
Rev Obstet Gynecol. 2013;6(1):e15-21.
7
Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.抗 HPA-1a 抗体重组治疗治疗胎儿母体内免疫性血小板减少症：在人类志愿者中的原理验证。
Blood. 2013 Jul 18;122(3):313-20. doi: 10.1182/blood-2013-02-481887. Epub 2013 May 8.
8
Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.通过去糖基化抗 HPA-1a 单克隆抗体抑制 HPA-1a 同种异体抗体介导的血小板破坏：针对胎儿同种免疫性血小板减少症的靶向治疗。
Blood. 2013 Jul 18;122(3):321-7. doi: 10.1182/blood-2012-11-468561. Epub 2013 May 3.
本文引用的文献
1
Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.胎儿同种免疫性血小板减少症和母亲静脉内免疫球蛋白输注。
Haematologica. 2010 Nov;95(11):1921-6. doi: 10.3324/haematol.2010.025106. Epub 2010 Jun 9.
2
Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus.同种免疫性血小板减少症所致颅内出血：分层管理以预防后续受影响胎儿的复发。
Am J Obstet Gynecol. 2010 Aug;203(2):135.e1-14. doi: 10.1016/j.ajog.2010.03.011. Epub 2010 May 21.
3
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.标准风险同种免疫性血小板减少症的产前治疗：一项不进行早期脐血穿刺的随机对照试验。
Obstet Gynecol. 2007 Aug;110(2 Pt 1):249-55. doi: 10.1097/01.AOG.0000270302.80336.dd.
4
Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective.胎儿及新生儿同种免疫性血小板减少症的无创产前管理：安全且有效。
BJOG. 2007 Apr;114(4):469-73. doi: 10.1111/j.1471-0528.2007.01244.x. Epub 2007 Feb 19.
5
Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage.
Am J Obstet Gynecol. 2006 Oct;195(4):1153-7. doi: 10.1016/j.ajog.2006.06.066.
6
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.胎儿同种免疫性血小板减少症基于风险治疗的平行随机试验。
Obstet Gynecol. 2006 Jan;107(1):91-6. doi: 10.1097/01.AOG.0000192404.25780.68.
7
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.新生儿同种免疫性血小板减少症与非免疫性血小板减少症的临床及诊断比较
Pediatr Blood Cancer. 2005 Aug;45(2):176-83. doi: 10.1002/pbc.20282.
8
Antenatal interventions for fetomaternal alloimmune thrombocytopenia.胎儿母体型同种免疫性血小板减少症的产前干预措施。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004226. doi: 10.1002/14651858.CD004226.pub2.
9
Management of fetal alloimmune thrombocytopenia-a less invasive option?
J Obstet Gynaecol. 1999 Mar;19(2):119-21. doi: 10.1080/01443619965372.
Zotero 插件